These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6204790)

  • 1. Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes.
    Parkinson EK; Pera MF; Emmerson A; Gorman PA
    Carcinogenesis; 1984 Aug; 5(8):1071-7. PubMed ID: 6204790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of human cervical keratinocytes in vitro to tumour promoters and diethylstilboestrol.
    Stanley MA; Crowcroft NS; Quigley JP; Parkinson EK
    Carcinogenesis; 1985 Jul; 6(7):1011-5. PubMed ID: 2410159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation.
    Parkinson EK; Grabham P; Emmerson A
    Carcinogenesis; 1983; 4(7):857-61. PubMed ID: 6191883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of tumour promoters on the multiplication and morphology of cultured human epidermal keratinocytes.
    Parkinson EK; Emmerson A
    Carcinogenesis; 1982; 3(5):525-31. PubMed ID: 6178528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase C mimics the differential effects of phorbol-12-myristate-13-acetate on the colony formation and cornification of cultured normal and transformed human keratinocytes.
    Parkinson EK
    Carcinogenesis; 1987 Jun; 8(6):857-60. PubMed ID: 2440613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second stage tumor promoters: differences in biological potency and phorbol ester receptor affinity in C6 cells.
    Leach KL; Frost MM; Blumberg PM; Bressler JP
    Cancer Lett; 1987 Aug; 36(2):139-47. PubMed ID: 3040225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency.
    Klein-Szanto AJ; Major SK; Slaga TJ
    Carcinogenesis; 1980 May; 1(5):399-406. PubMed ID: 6168406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters.
    Hennings H; Robinson VA; Michael DM; Pettit GR; Jung R; Yuspa SH
    Cancer Res; 1990 Aug; 50(15):4794-800. PubMed ID: 2114947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tumour promoter-induced prostaglandin E2 release in human and rat keratinocytes.
    Lawrence JN; Benford DJ
    Carcinogenesis; 1995 May; 16(5):1247-51. PubMed ID: 7767993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cells.
    Srinivas L; Colburn NH
    Cancer Res; 1984 Apr; 44(4):1510-4. PubMed ID: 6608408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester binding and protein kinase C activity in normal and transformed human keratinocytes.
    Snoek GT; Boonstra J; Ponec M; de Laat SW
    Exp Cell Res; 1987 Sep; 172(1):146-57. PubMed ID: 2443372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-promoting hyperplasiogenic agents do not mimic the effects of phorbol, 12-myristate, 13-acetate on terminal differentiation of normal and transformed human keratinocytes.
    Parkinson EK; Emmerson A
    Carcinogenesis; 1984 May; 5(5):687-90. PubMed ID: 6202432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of human myeloid leukemic cells by phorbol esters: correlation with tumor promotion.
    Fibach E; Agranat I; Rachmilewitz EA
    Int J Cancer; 1984 Oct; 34(4):451-7. PubMed ID: 6593308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding.
    Parkinson EK
    Br J Cancer; 1985 Oct; 52(4):479-93. PubMed ID: 2415144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes.
    Reiners JJ; Slaga TJ
    Cell; 1983 Jan; 32(1):247-55. PubMed ID: 6186392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin tumor promotion by phorbol esters is a two-stage process.
    Fürstenberger G; Berry DL; Sorg B; Marks F
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7722-6. PubMed ID: 6801661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single applications of 12-O-tetradecanoylphorbol-13-acetate, mezerein, or ethylphenylpropiolate on DNA synthesis and polyamine levels in hairless mouse epidermis.
    Paulsen JE; Astrup EG
    Cancer Res; 1983 Sep; 43(9):4126-31. PubMed ID: 6871854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-promoter-resistant cells lack trisialoganglioside response.
    Srinivas L; Gindhart TD; Colburn NH
    Proc Natl Acad Sci U S A; 1982 Aug; 79(16):4988-91. PubMed ID: 6956909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic hormones and tumor promoters greatly increase the incidence of colony-forming cells bearing amplified dihydrofolate reductase genes.
    Barsoum J; Varshavsky A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5330-4. PubMed ID: 6351057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of intercellular communication by tumor promoters.
    Murray AW; Fitzgerald DJ; Guy GR
    Carcinog Compr Surv; 1982; 7():587-91. PubMed ID: 7066930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.